News
-
Owners Masterclass at APP2025
Thursday | Feb 6 2025ESTABLISHED and aspiring pharmacy owners are invited to attend a pre-conference workshop at this year's APP titled 'Transforming the future of pharmacy - embracing change and innovation'.
-
Changes in opioid prescribing give hope
Wednesday | Feb 5 2025THERE is a concerning increase in new opioid prescriptions among younger people in Victoria, according to new research from Monash University.
-
Update on MHT: review
Wednesday | Feb 5 2025A RESEARCH review of evidence-based recommendations for menopause hormone therapy (MHT) has found that its impact differs significantly between demographics and use should be tailored to individual need.
-
Shingles awareness
Wednesday | Feb 5 2025MOST adults aged 50 and over are likely to be at risk of shingles, but many may not understand its cause, risk and impact.
-
Ramsey CEO shares career journey
Wednesday | Feb 5 2025THE latest episode of Your Pharmacy Career Podcast, hosted by Krysti-Lee Patterson, features an engaging and motivational discussion with Michelle Lynch, CEO of Ramsay Pharmacy and Psychology Group.
-
PSA lauds NT vax program
Tuesday | Feb 4 2025THE Pharmaceutical Society of Australia (PSA) has applauded the Northern Territory Government for its decision to increase the scope of pharmacist-administered vaccination.
-
AdPha calls for access equity
Tuesday | Feb 4 2025ADVANCED Pharmacy Australia (AdPha) has called for improved patient access to medicines and patient equity in its 2025-26 Federal Pre-Budget Submission, with scope of practice, workforce sustainability and drug shortages its key member priorities.
-
SA 24/7 pharmacy milestone
Tuesday | Feb 4 2025SOUTH Australia's first 24/7 pharmacy has helped more than 25,000 people and dispensed more than 12,500 prescriptions after hours since opening one year ago.
-
Grow in 2025
Tuesday | Feb 4 2025WITH its pharmacies growing their revenue by 36% over four years, Chemist Discount Centre provides an end-to-end franchise solution and an opportunity to grow.
-
F&P Healthcare feels Trump effect
Tuesday | Feb 4 2025NEW Zealand-based global medical device company Fisher & Paykel Healthcare has reported to the ASX that costs are forecast to increase under the new US tariff regime, which resulted in a 7.4% drop in share price.
